Umbilical Cord Derived Mesenchymal Stem Cells Therapy in Parkinson's Disease
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT03550183|
Recruitment Status : Enrolling by invitation
First Posted : June 8, 2018
Last Update Posted : December 30, 2021
Hebei Newtherapy BIo-Pharma technology Co., Ltd.
Information provided by (Responsible Party):
Shengjun An, Hebei Newtherapy BIo-Pharma technology Co., Ltd.
No Study Results Posted on ClinicalTrials.gov for this Study
|Recruitment Status :||Enrolling by invitation|
|Estimated Primary Completion Date :||October 10, 2022|
|Estimated Study Completion Date :||December 30, 2022|